2023年3期
亞洲社會藥學(xué)雜志
Drug Supervision
- Research Progress in FDA’s Focus Areas of Regulatory Science for Drugs and Suggestions for China
- Supervision of Public Opinion under the Background of Social Co-governance-Take the Changsheng Vaccine Incident as an Example
- Suggestions for Promoting China’s Drug Regulatory Agency to Join Pharmaceutical Inspection Co-operation Scheme -PIC/S
- Analysis and Enlightenment of Big Data Platform for Adverse Drug Reaction Supervision in China and the United States
- An Empirical Study on Organizational Efficiency of Drug Review lnstitutions